Human T Lymphotropic Virus Type I (HTLV-I)-AssociatedMyelopathy/Tropical Spastic Paraparesis (HAM/TSP). Recent Perspectives.
-
- IJICHI Shinji
- the Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University
-
- OSAME Mitsuhiro
- the Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University
この論文をさがす
抄録
Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a well-defined clinicopathological entity, and approximately 1, 900 patients with HAM/TSP have been reported in the world. Improved polymerase chain reaction (PCR)-based in situ techniques have allowed a better appreciation of the cellular localization of the virus activation in infected patients, and there is accumulating evidence that HAM/TSP is characterized by a distributional bias of viral activation between the blood flow and central nervous system (CNS). This review summarizes the current status of our understanding of HAM/TSP, and emphasizes the possible pathogenic involvement of cellular interactions between infected cells and responding immunocompetent cells in the CNS of patients with HAM/TSP. In addition, the notable systemic manifestations with or without myelopathy in HTLV-I-infected individuals are described.<br>(Internal Medicine 34: 713-721, 1995)
収録刊行物
-
- Internal Medicine
-
Internal Medicine 34 (8), 713-721, 1995
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679843686272
-
- NII論文ID
- 10006168979
-
- NII書誌ID
- AA10827774
-
- COI
- 1:STN:280:BymD1cros1Y%3D
-
- ISSN
- 13497235
- 09182918
-
- PubMed
- 8563108
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可